Medically supervised body composition transformation. GLP-1 receptor agonist for appetite regulation, combined with three metabolic support compounds that enhance insulin sensitivity, stabilize blood sugar, and support gut health.
arq Recomp combines the most potent appetite-regulatory pharmaceutical with three metabolic enhancers. Semaglutide reduces hunger via GLP-1 signaling. Berberine activates AMPK for metabolic support. Chromium improves insulin sensitivity. Psyllium feeds the microbiome and slows glucose absorption.
Semaglutide is the appetite suppressor. Berberine activates AMPK for metabolic support. Chromium optimises insulin sensitivity. Psyllium stabilises blood sugar and feeds the microbiome. Together, this addresses body recomposition from multiple angles: appetite control, insulin sensitivity, metabolic activation, and gut health.
Book a consultation with a licensed physician to discuss whether arq Recomp is appropriate for you.